Can Fatty Liver Be Hereditary?
Yes, fatty liver disease has a strong hereditary component, with genetic factors playing a major role in determining whether an individual develops the condition.
The Genetic Evidence
Fatty liver disease demonstrates substantial heritability through multiple mechanisms:
Specific Genetic Variants
Several genetic variants significantly increase the risk of developing fatty liver disease 1. The most well-established is the PNPLA3 gene variant (rs738409, encoding the I148M substitution), first identified in 2008. Carriers of this risk allele face higher risk across the entire spectrum of liver disease—from simple steatosis to inflammation, fibrosis, and cirrhosis. These individuals are also diagnosed earlier and have increased liver-related mortality 1.
Other identified genetic variants include those in HSD17B13, MBOAT7, GPAM, and CIDEB genes, all affecting hepatocyte lipid droplet homeostasis 1. This genetic susceptibility comprises both common and rare gene variants that cumulatively increase NAFLD risk 1.
Familial Aggregation Studies
The heritability is strikingly high in family studies:
The narrow-sense heritability of fatty liver was calculated at 1.000 (essentially 100%) when adjusted for age, sex, race, and BMI 2. This represents one of the strongest genetic components seen in any common disease.
In families with NAFLD probands, 59% of siblings and 78% of parents had fatty liver, compared to only 17% of siblings and 37% of parents in families without NAFLD 2.
Children with either parent having NAFLD showed 1.75 times higher odds of developing NAFLD themselves 3. The risk escalates further: paternal NAFLD alone conferred 1.80 times higher odds, maternal NAFLD 2.21 times, and both parents with NAFLD increased the risk 2.60-fold 3.
Clinical Recognition in Guidelines
The 2024 EASL-EASD-EASO guidelines explicitly recognize familial aggregation of steatotic liver disease as supporting a genetic disease, particularly for early-onset cases 4. The guidelines recommend considering genetic causes when common risk factors have been excluded, especially when there is a positive family history of advanced disease in first-degree relatives 4.
Important Clinical Implications
Screening Recommendations
Family members of individuals with NAFLD should be considered at high risk and warrant screening 5, 2. This is particularly important because:
- Screening parents of NAFLD patients can detect undiagnosed cases among them 5
- The prevalence of NAFLD-associated genetic variants (like ABHD5 mutations) may be as high as 1 in 1,137 individuals in the general population 6
The Gene-Environment Interaction
While genetics plays a dominant role, fatty liver disease typically results from chronic positive energy balance leading to obesity on a background of genetic susceptibility 1. The correlation between liver fat fraction and BMI is significantly stronger in families with NAFLD compared to those without 2, suggesting genes modify how environmental factors (diet, obesity) translate into liver disease.
Rare Hereditary Forms
Beyond common genetic variants, true Mendelian inheritance patterns exist:
Monoallelic ABHD5 mutations cause autosomal dominant NAFLD and/or dyslipidemia, with complete clinical expression typically after age 40 6. This represents the first reported mendelian inheritance pattern in NAFLD families, affecting 39 individuals across 7 unrelated families 6.
Hereditary fructose intolerance (aldolase B deficiency) is associated with fatty liver even in treated patients 7.
Bottom Line for Clinical Practice
Familial factors are a major determinant of whether an individual develops NAFLD 2. When evaluating a patient with fatty liver, obtain a detailed family history. When diagnosing NAFLD, inform the patient that their first-degree relatives face substantially elevated risk and should undergo screening with liver imaging and metabolic assessment. The genetic component is strong enough that it should influence your clinical suspicion and screening thresholds in family members, even when traditional metabolic risk factors are not prominently present.